QIA:FRA
Qiagen NV
€40.78
arrow_upward
+1.18%(+0.47) 1D
Oct 7, 2:24:07 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QIA...
Open
€40.26
High
€40.78
Low
€40.26
Mkt. cap
8.26B
Avg. vol.
580.00
Volume
430.00
Dividend
0.75%
Quarterly dividend
€0.08
Ex-dividend date
Jul 7, 2026
P/E ratio
23.54
52-wk high
€48.80
52-wk low
€27.86
EPS
€1.73
Shares outstanding
226.24M
No. of employees
6K
Open
€40.26
High
€40.78
Low
€40.26
Mkt. cap
8.26B
Avg. vol.
580.00
Volume
430.00
Dividend
0.75%
Quarterly dividend
€0.08
Ex-dividend date
Jul 7, 2026
P/E ratio
23.54
52-wk high
€48.80
52-wk low
€27.86
EPS
€1.73
Shares outstanding
226.24M
No. of employees
6K
News stories
From web sources and news partners
AD HOC NEWS
·
6 hours ago
Qiagen stock gets a new AI growth story from QIAGEN
AD HOC NEWS
·
10 hours ago
Barclays raises target for Qiagen stock from USD 40.00 to USD 55.00
TipRanks
·
21 hours ago
BlackRock lifts indirect stake in Qiagen to over 11%
TradingView
·
22 hours ago
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG
Profile
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer. Wikipedia
About Qiagen NV
CEOThierry Bernard
Employees5.5K
FoundedNov 29, 1984
HeadquartersVenlo, Limburg, Netherlands
SectorHealth care
Websiteqiagen.com